ArticleBreast cancer research and treatment2025

Comparison of paclitaxel and docetaxel in dual HER2 blockade: efficacy and safety in neoadjuvant treatment of HER2-positive breast cancer.

Ezgi Turkoglu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.